ProCE Banner Activity

Emergence of Resistance Mutations in People Living With HIV Receiving Second-Generation INSTIs

Conference Coverage
Slideset

This study reports subsequent INSTI resistance associated mutations, including the R263K mutant, among people living with HIV who experienced treatment failure after receiving second generation INSTI-based ART.

Released: March 11, 2024

Expiration: March 10, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare